You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 163 No. 22, December 8, 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Review Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on ISI (7)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Renal Diseases, Other
 •Review
 •Cardiovascular System, Other
 •Alert me on articles by topic

Role of the Natriuretic Peptide System in Cardiorenal Protection

Samy I. McFarlane, MD; Nathaniel Winer, MD; James R. Sowers, MD

Arch Intern Med. 2003;163:2696-2704.

Significant progress has been made in the understanding of the neurohormonal factors that contribute to the progression of chronic renal and cardiac failure and the development of target-organ damage in patients with hypertension and diabetes.1-3 We herein review some of these advances, including a new therapeutic strategy for potentially enhancing cardiorenal protection in patients with these disorders.


From the Division of Endocrinology, Diabetes, and Hypertension, Department of Medicine, State University of New York Health Science Center at Brooklyn and Kings County Hospital Centers of Brooklyn. The authors have no relevant financial interest in this article.







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.